ID

26737

Description

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Third party follow-up - Repeating form (Scheduled/Dynamic visit)

Keywords

Versions (3)
  1. 10/12/17 10/12/17 -
  2. 10/23/17 10/23/17 -
  3. 1/2/18 1/2/18 -
Copyright Holder

GlaxoSmithKline

Uploaded on

October 23, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

English

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

1 forms  
Date of last contact attempt
Description

Date of last contact attempt

1. Date of most recent attempt to contact third party
Description

Date of last contact attempt

Data type

date

Contact details
Description

Contact details

2. Was contact successful? (i.e. actually spoke to someone)
Description

contact successful

Data type

boolean

If contact successful: Type of third party contact
Description

Type of third party contact

Data type

text

Other type of third party contact
Description

Other type of third party contact

Data type

text

Are there any new study endpoints to report?
Description

If Yes, complete SAE-EP and appropriate Endpoint forms.

Data type

text

Date endpoint information assessed by third party
Description

Date endpoint information assessed by third party

Data type

date

Back to the top of the page

Similar models

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Date of last contact attempt
Date of last contact attempt
Item
1. Date of most recent attempt to contact third party
date
Item Group
Contact details
contact successful
Item
2. Was contact successful? (i.e. actually spoke to someone)
boolean
Item
If contact successful: Type of third party contact
text
Type of third party contact
Code List
If contact successful: Type of third party contact
CL Item
Investigative site staff (4)
CL Item
Health care provider other than investigative site staff (1)
CL Item
Family member (2)
CL Item
Friend or neighbor (5)
CL Item
Other (OT)
Other type of third party contact
Item
Other type of third party contact
text
Item
Are there any new study endpoints to report?
text
new study endpoints
Code List
Are there any new study endpoints to report?
CL Item
Unknown (Third party not able to find out if subject did or did not have new study endpoint, or the only information available is vital status "death" without details) (U)
CL Item
No (Third party able to confirm no new study endpoints) (N)
CL Item
Yes (Third party able to confirm the presence of new study endpoints. Do not select this option if the only information available is vital status "death" without details) (Y)
Date endpoint information assessed by third party
Item
Date endpoint information assessed by third party
date
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial